An Open Label, Single Treatment, Single Arm, Multiple Dose Phase-2 Study to Evaluate the Pharmacokinetics, Safety, and Clinical Performance of EscharEx (EX-03) in Participants With Venous Leg Ulcers
18h agoen
From the article
Conditions : Venous Leg Ulcer (VLU) Interventions : Drug: EX-03 Sponsors : MediWound Ltd; TFS HealthScience Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Anixa Biosciences Aktie: Höchste Lira-cel-Dosis erreicht
aktiencheck.de
GSK and Xenoport resubmit new drug application for Solzira™ in restless legs syndrome
GSK·17y ago
GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer
GSK·17y ago
Especialista critica Virginia Fonseca por recomendar soroterapia sem respaldo científico
Diário do Estado de São Paulo·4h ago
Un nuevo fármaco disminuye a la mitad los días de migraña en pacientes sin otras opciones
lavanguardia.com·1d ago
https://doi.org/10.1056/NEJMoa2517384
doi.org·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.